Our findings indicate that radical prostatectomy without prior biopsy is feasible in terms of the diagnosis of clinically significant PCa when proper preoperative risk stratification including mpMRI and PSMA-PET imaging is applied. The gene discussed is FOLH1; the disease is posterior cortical atrophy.